pmc-enju-pas Home  

PMC:1310901 / 13058-14324 JSONTXT 17 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T6221 0-7 NN denotes Absence
T6222 8-10 IN denotes of
T6223 11-16 NN denotes IRF-4
T6224 17-27 NN denotes expression
T6225 28-30 IN denotes in
T6226 31-39 NN denotes leukemia
T6227 40-45 NN denotes cells
T6228 46-48 VB denotes is
T6229 49-52 RB denotes not
T6230 53-56 JJ denotes due
T6231 57-59 TO denotes to
T6232 60-68 NN denotes promoter
T6233 69-80 NN denotes alterations
T6234 81-83 PRP denotes We
T6235 84-88 VB denotes have
T6236 89-99 RB denotes previously
T6237 100-112 VB denotes demonstrated
T6238 113-114 DT denotes a
T6239 115-119 NN denotes lack
T6240 120-122 IN denotes of
T6241 123-128 NN denotes IRF-4
T6242 129-139 NN denotes expression
T6243 140-142 IN denotes in
T6244 143-151 NN denotes leukemia
T6245 152-160 NN denotes patients
T6246 161-164 CC denotes and
T6247 165-177 RB denotes specifically
T6248 178-180 IN denotes in
T6249 181-184 NN denotes CML
T6250 185-192 NN denotes T-cells
T6251 193-194 -LRB- denotes (
T6252 194-195 CD denotes 3
T6253 195-196 -RRB- denotes )
T6254 198-202 RB denotes Here
T6255 202-203 -COMMA- denotes ,
T6256 204-206 PRP denotes we
T6257 207-218 VB denotes demonstrate
T6258 219-222 DT denotes the
T6259 223-230 NN denotes absence
T6260 231-233 IN denotes of
T6261 234-239 NN denotes IRF-4
T6262 240-250 NN denotes expression
T6263 251-253 IN denotes in
T6264 254-261 JJ denotes various
T6265 262-275 JJ denotes hematopoietic
T6266 276-280 NN denotes cell
T6267 281-286 NN denotes lines
T6268 286-287 -COMMA- denotes ,
T6269 288-292 JJ denotes such
T6270 293-295 IN denotes as
T6271 296-302 NN denotes Jurkat
T6272 302-303 -COMMA- denotes ,
T6273 304-305 DT denotes a
T6274 306-312 NN denotes T-cell
T6275 313-321 NN denotes leukemia
T6276 321-322 -COMMA- denotes ,
T6277 323-329 NN denotes CML-T1
T6278 329-330 -COMMA- denotes ,
T6279 331-332 DT denotes a
T6280 333-349 JJ denotes bcr-abl-positive
T6281 350-356 NN denotes T-cell
T6282 357-361 NN denotes line
T6283 361-362 -COMMA- denotes ,
T6284 363-368 NN denotes K-562
T6285 368-369 -COMMA- denotes ,
T6286 370-371 DT denotes a
T6287 372-387 JJ denotes bcr-abl-positve
T6288 388-403 NN denotes erythroleukemia
T6289 403-404 -COMMA- denotes ,
T6290 405-410 NN denotes U-937
T6291 410-411 -COMMA- denotes ,
T6292 412-413 DT denotes a
T6293 414-423 JJ denotes monocytic
T6294 424-432 NN denotes leukemia
T6295 432-433 -COMMA- denotes ,
T6296 434-438 NN denotes EM-2
T6297 439-442 CC denotes and
T6298 443-450 NN denotes LAMA-84
T6299 450-451 -COMMA- denotes ,
T6300 452-467 JJ denotes bcr-abl-positve
T6301 468-475 JJ denotes myeloid
T6302 476-484 NN denotes leukemia
T6303 484-485 -COMMA- denotes ,
T6304 486-489 CC denotes but
T6305 490-493 RB denotes not
T6306 494-496 IN denotes in
T6307 497-501 NN denotes SD-1
T6308 501-502 -COMMA- denotes ,
T6309 503-504 DT denotes a
T6310 505-521 JJ denotes bcr-abl-positive
T6311 522-527 JJ denotes acute
T6312 528-541 JJ denotes lymphoblastic
T6313 542-550 NN denotes leukemia
T6314 551-552 -LRB- denotes (
T6315 552-555 JJ denotes pre
T6316 556-561 NN denotes B-ALL
T6317 561-562 -RRB- denotes )
T6318 562-563 -COMMA- denotes ,
T6319 564-573 NN denotes RPMI-8226
T6320 573-574 -COMMA- denotes ,
T6321 575-576 DT denotes a
T6322 577-585 JJ denotes multiple
T6323 586-593 NN denotes myeloma
T6324 594-597 CC denotes and
T6325 598-604 NN denotes BV-173
T6326 604-605 -COMMA- denotes ,
T6327 606-607 DT denotes a
T6328 608-624 JJ denotes bcr-abl-positive
T6329 625-631 NN denotes B-cell
T6330 632-636 NN denotes line
T6331 637-638 -LRB- denotes (
T6332 638-645 NN denotes Figures
T6333 646-648 NN denotes 1A
T6334 649-652 CC denotes and
T6335 653-655 NN denotes 5D
T6336 655-656 -RRB- denotes )
T6337 658-663 IN denotes After
T6338 664-674 NN denotes sequencing
T6339 675-677 IN denotes of
T6340 678-681 DT denotes the
T6341 682-687 NN denotes IRF-4
T6342 688-696 NN denotes promoter
T6343 696-697 -COMMA- denotes ,
T6344 698-700 PRP denotes it
T6345 701-706 MD denotes could
T6346 707-709 VB denotes be
T6347 710-718 VB denotes excluded
T6348 719-723 IN denotes that
T6349 724-731 NN denotes absence
T6350 732-734 IN denotes of
T6351 735-740 NN denotes IRF-4
T6352 741-751 NN denotes expression
T6353 752-754 IN denotes in
T6354 755-758 DT denotes any
T6355 759-761 IN denotes of
T6356 762-765 DT denotes the
T6357 766-771 JJ denotes above
T6358 772-776 NN denotes cell
T6359 777-782 NN denotes lines
T6360 783-786 VB denotes was
T6361 787-790 JJ denotes due
T6362 791-793 TO denotes to
T6363 794-801 JJ denotes genetic
T6364 802-813 NN denotes aberrations
T6365 815-822 RB denotes However
T6366 822-823 -COMMA- denotes ,
T6367 824-825 CD denotes 2
T6368 826-828 NN denotes bp
T6369 829-836 NN denotes changes
T6370 837-838 -LRB- denotes (
T6371 838-848 NN denotes nucleotide
T6372 849-854 NN denotes −1081
T6373 854-855 -COMMA- denotes ,
T6374 856-859 NN denotes T→C
T6375 860-863 CC denotes and
T6376 864-869 CD denotes −1068
T6377 869-870 -COMMA- denotes ,
T6378 871-874 NN denotes A→C
T6379 874-875 -RRB- denotes )
T6380 876-881 MD denotes could
T6381 882-884 VB denotes be
T6382 885-893 VB denotes detected
T6383 894-896 IN denotes in
T6384 897-901 CC denotes both
T6385 902-905 DT denotes the
T6386 906-920 JJ denotes IRF-4-positive
T6387 921-927 NN denotes BV-173
T6388 928-931 CC denotes and
T6389 932-935 DT denotes the
T6390 936-950 JJ denotes IRF-4-negative
T6391 951-958 NN denotes LAMA-84
T6392 958-959 -COMMA- denotes ,
T6393 960-964 NN denotes EM-2
T6394 965-968 CC denotes and
T6395 969-974 NN denotes K-562
T6396 975-976 -LRB- denotes (
T6397 976-982 NN denotes Figure
T6398 983-985 NN denotes 1B
T6399 985-986 -RRB- denotes )
T6400 988-990 IN denotes At
T6401 991-999 NN denotes position
T6402 1000-1004 CD denotes −116
T6403 1005-1007 DT denotes an
T6404 1008-1011 NN denotes A→C
T6405 1012-1024 NN denotes substitution
T6406 1025-1028 VB denotes was
T6407 1029-1034 VB denotes found
T6408 1035-1037 IN denotes in
T6409 1038-1042 NN denotes EM-2
T6410 1042-1043 -COMMA- denotes ,
T6411 1044-1049 NN denotes K-562
T6412 1050-1053 CC denotes and
T6413 1054-1060 NN denotes CML-T1
T6414 1060-1061 -COMMA- denotes ,
T6415 1062-1069 IN denotes whereas
T6416 1070-1076 NN denotes Jurkat
T6417 1076-1077 -COMMA- denotes ,
T6418 1078-1084 NN denotes BV-173
T6419 1085-1088 CC denotes and
T6420 1089-1093 NN denotes SD-1
T6421 1094-1103 VB denotes exhibited
T6422 1104-1105 DT denotes a
T6423 1106-1111 VB denotes mixed
T6424 1112-1115 NN denotes A/C
T6425 1116-1124 NN denotes sequence
T6426 1125-1128 CC denotes and
T6427 1129-1134 NN denotes U-937
T6428 1134-1135 -COMMA- denotes ,
T6429 1136-1143 NN denotes LAMA-84
T6430 1144-1147 CC denotes and
T6431 1148-1157 NN denotes RPMI-8226
T6432 1158-1160 DT denotes no
T6433 1161-1173 NN denotes substitution
T6434 1174-1176 IN denotes at
T6435 1177-1180 DT denotes all
T6436 1181-1182 -LRB- denotes (
T6437 1182-1188 NN denotes Figure
T6438 1189-1191 NN denotes 1B
T6439 1191-1192 -RRB- denotes )
T6440 1194-1206 RB denotes Consequently
T6441 1206-1207 -COMMA- denotes ,
T6442 1208-1213 DT denotes these
T6443 1214-1225 NN denotes alterations
T6444 1226-1229 VB denotes are
T6445 1230-1238 JJ denotes unlikely
T6446 1239-1241 TO denotes to
T6447 1242-1248 VB denotes affect
T6448 1249-1254 NN denotes IRF-4
T6449 1255-1265 NN denotes expression
R5176 T6221 T6222 arg1Of Absence,of
R5177 T6221 T6228 arg1Of Absence,is
R5178 T6221 T6230 arg1Of Absence,due
R5179 T6224 T6222 arg2Of expression,of
R5180 T6224 T6223 arg1Of expression,IRF-4
R5181 T6224 T6225 arg1Of expression,in
R5182 T6227 T6225 arg2Of cells,in
R5183 T6227 T6226 arg1Of cells,leukemia
R5184 T6228 T6229 arg1Of is,not
R5185 T6230 T6228 arg2Of due,is
R5186 T6230 T6231 arg1Of due,to
R5187 T6233 T6231 arg2Of alterations,to
R5188 T6233 T6232 arg1Of alterations,promoter
R5189 T6234 T6235 arg1Of We,have
R5190 T6234 T6237 arg1Of We,demonstrated
R5191 T6237 T6235 arg2Of demonstrated,have
R5192 T6237 T6236 arg1Of demonstrated,previously
R5193 T6239 T6237 arg2Of lack,demonstrated
R5194 T6239 T6238 arg1Of lack,a
R5195 T6239 T6240 arg1Of lack,of
R5196 T6239 T6243 arg1Of lack,in
R5197 T6239 T6248 arg1Of lack,in
R5198 T6242 T6240 arg2Of expression,of
R5199 T6242 T6241 arg1Of expression,IRF-4
R5200 T6243 T6246 arg1Of in,and
R5201 T6245 T6243 arg2Of patients,in
R5202 T6245 T6244 arg1Of patients,leukemia
R5203 T6248 T6246 arg2Of in,and
R5204 T6248 T6247 arg1Of in,specifically
R5205 T6250 T6248 arg2Of T-cells,in
R5206 T6250 T6249 arg1Of T-cells,CML
R5207 T6250 T6251 arg1Of T-cells,(
R5208 T6252 T6251 arg2Of 3,(
R5209 T6253 T6251 arg3Of ),(
R5210 T6256 T6257 arg1Of we,demonstrate
R5211 T6257 T6254 arg1Of demonstrate,Here
R5212 T6257 T6255 arg1Of demonstrate,","
R5213 T6259 T6258 arg1Of absence,the
R5214 T6259 T6260 arg1Of absence,of
R5215 T6259 T6306 arg1Of absence,in
R5216 T6259 T6318 arg1Of absence,","
R5217 T6259 T6324 arg1Of absence,and
R5218 T6260 T6304 arg1Of of,but
R5219 T6262 T6260 arg2Of expression,of
R5220 T6262 T6261 arg1Of expression,IRF-4
R5221 T6262 T6263 arg1Of expression,in
R5222 T6262 T6278 arg1Of expression,","
R5223 T6262 T6289 arg1Of expression,","
R5224 T6262 T6291 arg1Of expression,","
R5225 T6267 T6263 arg2Of lines,in
R5226 T6267 T6264 arg1Of lines,various
R5227 T6267 T6265 arg1Of lines,hematopoietic
R5228 T6267 T6266 arg1Of lines,cell
R5229 T6267 T6268 arg1Of lines,","
R5230 T6267 T6270 arg1Of lines,as
R5231 T6270 T6269 arg1Of as,such
R5232 T6271 T6270 arg2Of Jurkat,as
R5233 T6271 T6272 arg1Of Jurkat,","
R5234 T6271 T6276 arg1Of Jurkat,","
R5235 T6275 T6272 arg2Of leukemia,","
R5236 T6275 T6273 arg1Of leukemia,a
R5237 T6275 T6274 arg1Of leukemia,T-cell
R5238 T6277 T6276 arg2Of CML-T1,","
R5239 T6282 T6278 arg2Of line,","
R5240 T6282 T6279 arg1Of line,a
R5241 T6282 T6280 arg1Of line,bcr-abl-positive
R5242 T6282 T6281 arg1Of line,T-cell
R5243 T6282 T6283 arg1Of line,","
R5244 T6282 T6285 arg1Of line,","
R5245 T6284 T6283 arg2Of K-562,","
R5246 T6288 T6285 arg2Of erythroleukemia,","
R5247 T6288 T6286 arg1Of erythroleukemia,a
R5248 T6288 T6287 arg1Of erythroleukemia,bcr-abl-positve
R5249 T6290 T6289 arg2Of U-937,","
R5250 T6294 T6295 arg1Of leukemia,","
R5251 T6295 T6297 arg1Of ",",and
R5252 T6296 T6295 arg2Of EM-2,","
R5253 T6297 T6293 arg1Of and,monocytic
R5254 T6297 T6299 arg1Of and,","
R5255 T6298 T6297 arg2Of LAMA-84,and
R5256 T6299 T6291 arg2Of ",",","
R5257 T6299 T6292 arg1Of ",",a
R5258 T6302 T6299 arg2Of leukemia,","
R5259 T6302 T6300 arg1Of leukemia,bcr-abl-positve
R5260 T6302 T6301 arg1Of leukemia,myeloid
R5261 T6304 T6303 arg1Of but,","
R5262 T6306 T6304 arg2Of in,but
R5263 T6306 T6305 arg1Of in,not
R5264 T6307 T6306 arg2Of SD-1,in
R5265 T6307 T6308 arg1Of SD-1,","
R5266 T6313 T6308 arg2Of leukemia,","
R5267 T6313 T6309 arg1Of leukemia,a
R5268 T6313 T6310 arg1Of leukemia,bcr-abl-positive
R5269 T6313 T6311 arg1Of leukemia,acute
R5270 T6313 T6312 arg1Of leukemia,lymphoblastic
R5271 T6313 T6314 arg1Of leukemia,(
R5272 T6316 T6314 arg2Of B-ALL,(
R5273 T6316 T6315 arg1Of B-ALL,pre
R5274 T6317 T6314 arg3Of ),(
R5275 T6319 T6318 arg2Of RPMI-8226,","
R5276 T6319 T6320 arg1Of RPMI-8226,","
R5277 T6323 T6320 arg2Of myeloma,","
R5278 T6323 T6321 arg1Of myeloma,a
R5279 T6323 T6322 arg1Of myeloma,multiple
R5280 T6324 T6257 arg2Of and,demonstrate
R5281 T6325 T6324 arg2Of BV-173,and
R5282 T6325 T6326 arg1Of BV-173,","
R5283 T6330 T6326 arg2Of line,","
R5284 T6330 T6327 arg1Of line,a
R5285 T6330 T6328 arg1Of line,bcr-abl-positive
R5286 T6330 T6329 arg1Of line,B-cell
R5287 T6330 T6331 arg1Of line,(
R5288 T6333 T6334 arg1Of 1A,and
R5289 T6334 T6331 arg2Of and,(
R5290 T6334 T6332 arg1Of and,Figures
R5291 T6335 T6334 arg2Of 5D,and
R5292 T6336 T6331 arg3Of ),(
R5293 T6338 T6337 arg2Of sequencing,After
R5294 T6338 T6339 arg1Of sequencing,of
R5295 T6342 T6339 arg2Of promoter,of
R5296 T6342 T6340 arg1Of promoter,the
R5297 T6342 T6341 arg1Of promoter,IRF-4
R5298 T6344 T6345 arg1Of it,could
R5299 T6344 T6346 arg1Of it,be
R5300 T6346 T6337 arg1Of be,After
R5301 T6346 T6343 arg1Of be,","
R5302 T6346 T6345 arg2Of be,could
R5303 T6346 T6353 arg1Of be,in
R5304 T6349 T6346 arg2Of absence,be
R5305 T6349 T6347 arg2Of absence,excluded
R5306 T6349 T6348 arg1Of absence,that
R5307 T6349 T6350 arg1Of absence,of
R5308 T6352 T6350 arg2Of expression,of
R5309 T6352 T6351 arg1Of expression,IRF-4
R5310 T6354 T6355 arg1Of any,of
R5311 T6354 T6360 arg1Of any,was
R5312 T6354 T6361 arg1Of any,due
R5313 T6359 T6355 arg2Of lines,of
R5314 T6359 T6356 arg1Of lines,the
R5315 T6359 T6357 arg1Of lines,above
R5316 T6359 T6358 arg1Of lines,cell
R5317 T6360 T6353 arg2Of was,in
R5318 T6361 T6360 arg2Of due,was
R5319 T6361 T6362 arg1Of due,to
R5320 T6364 T6362 arg2Of aberrations,to
R5321 T6364 T6363 arg1Of aberrations,genetic
R5322 T6369 T6367 arg1Of changes,2
R5323 T6369 T6368 arg1Of changes,bp
R5324 T6369 T6370 arg1Of changes,(
R5325 T6369 T6380 arg1Of changes,could
R5326 T6369 T6381 arg1Of changes,be
R5327 T6369 T6382 arg2Of changes,detected
R5328 T6372 T6371 arg1Of −1081,nucleotide
R5329 T6372 T6373 arg1Of −1081,","
R5330 T6373 T6375 arg1Of ",",and
R5331 T6374 T6373 arg2Of T→C,","
R5332 T6375 T6370 arg2Of and,(
R5333 T6375 T6377 arg1Of and,","
R5334 T6376 T6375 arg2Of −1068,and
R5335 T6378 T6377 arg2Of A→C,","
R5336 T6379 T6370 arg3Of ),(
R5337 T6382 T6365 arg1Of detected,However
R5338 T6382 T6366 arg1Of detected,","
R5339 T6382 T6380 arg2Of detected,could
R5340 T6382 T6381 arg2Of detected,be
R5341 T6382 T6383 arg1Of detected,in
R5342 T6387 T6385 arg1Of BV-173,the
R5343 T6387 T6386 arg1Of BV-173,IRF-4-positive
R5344 T6387 T6388 arg1Of BV-173,and
R5345 T6388 T6383 arg2Of and,in
R5346 T6388 T6384 arg1Of and,both
R5347 T6388 T6392 arg1Of and,","
R5348 T6391 T6388 arg2Of LAMA-84,and
R5349 T6391 T6389 arg1Of LAMA-84,the
R5350 T6391 T6390 arg1Of LAMA-84,IRF-4-negative
R5351 T6393 T6394 arg1Of EM-2,and
R5352 T6394 T6392 arg2Of and,","
R5353 T6394 T6396 arg1Of and,(
R5354 T6395 T6394 arg2Of K-562,and
R5355 T6398 T6396 arg2Of 1B,(
R5356 T6398 T6397 arg1Of 1B,Figure
R5357 T6399 T6396 arg3Of ),(
R5358 T6401 T6400 arg2Of position,At
R5359 T6401 T6402 arg1Of position,−116
R5360 T6405 T6403 arg1Of substitution,an
R5361 T6405 T6404 arg1Of substitution,A→C
R5362 T6405 T6406 arg1Of substitution,was
R5363 T6405 T6407 arg2Of substitution,found
R5364 T6407 T6400 arg1Of found,At
R5365 T6407 T6406 arg2Of found,was
R5366 T6407 T6408 arg1Of found,in
R5367 T6407 T6415 arg1Of found,whereas
R5368 T6409 T6410 arg1Of EM-2,","
R5369 T6410 T6412 arg1Of ",",and
R5370 T6411 T6410 arg2Of K-562,","
R5371 T6412 T6408 arg2Of and,in
R5372 T6413 T6412 arg2Of CML-T1,and
R5373 T6415 T6414 arg1Of whereas,","
R5374 T6416 T6417 arg1Of Jurkat,","
R5375 T6417 T6419 arg1Of ",",and
R5376 T6418 T6417 arg2Of BV-173,","
R5377 T6419 T6421 arg1Of and,exhibited
R5378 T6420 T6419 arg2Of SD-1,and
R5379 T6421 T6415 arg2Of exhibited,whereas
R5380 T6422 T6431 arg1Of a,RPMI-8226
R5381 T6425 T6423 arg2Of sequence,mixed
R5382 T6425 T6424 arg1Of sequence,A/C
R5383 T6425 T6426 arg1Of sequence,and
R5384 T6426 T6421 arg2Of and,exhibited
R5385 T6426 T6422 arg1Of and,a
R5386 T6426 T6434 arg1Of and,at
R5387 T6426 T6436 arg1Of and,(
R5388 T6427 T6428 arg1Of U-937,","
R5389 T6428 T6430 arg1Of ",",and
R5390 T6429 T6428 arg2Of LAMA-84,","
R5391 T6430 T6426 arg2Of and,and
R5392 T6431 T6430 arg2Of RPMI-8226,and
R5393 T6433 T6431 arg2Of substitution,RPMI-8226
R5394 T6433 T6432 arg1Of substitution,no
R5395 T6434 T6435 arg1Of at,all
R5396 T6438 T6436 arg2Of 1B,(
R5397 T6438 T6437 arg1Of 1B,Figure
R5398 T6439 T6436 arg3Of ),(
R5399 T6443 T6442 arg1Of alterations,these
R5400 T6443 T6444 arg1Of alterations,are
R5401 T6443 T6445 arg1Of alterations,unlikely
R5402 T6443 T6447 arg1Of alterations,affect
R5403 T6444 T6440 arg1Of are,Consequently
R5404 T6444 T6441 arg1Of are,","
R5405 T6445 T6444 arg2Of unlikely,are
R5406 T6447 T6445 arg2Of affect,unlikely
R5407 T6447 T6446 arg1Of affect,to
R5408 T6449 T6447 arg2Of expression,affect
R5409 T6449 T6448 arg1Of expression,IRF-4